These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18647623)

  • 21. Treatment of mitochondrial cytopathies.
    Gold DR; Cohen BH
    Semin Neurol; 2001 Sep; 21(3):309-25. PubMed ID: 11641821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of mitochondrial disorders.
    Finsterer J
    Eur J Paediatr Neurol; 2010 Jan; 14(1):29-44. PubMed ID: 19692274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-induced mitochondrial damage and disease.
    Neustadt J; Pieczenik SR
    Mol Nutr Food Res; 2008 Jul; 52(7):780-8. PubMed ID: 18626887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by alpha-lipoic acid.
    Vanasco V; Cimolai MC; Evelson P; Alvarez S
    Free Radic Res; 2008 Sep; 42(9):815-23. PubMed ID: 19051079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-gamma coactivator-1alpha.
    McCarty MF; Barroso-Aranda J; Contreras F
    Med Hypotheses; 2009 Jan; 72(1):29-33. PubMed ID: 18789599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.
    Depeint F; Bruce WR; Shangari N; Mehta R; O'Brien PJ
    Chem Biol Interact; 2006 Oct; 163(1-2):94-112. PubMed ID: 16765926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency.
    Kang HC; Kim HD; Lee YM; Han SH
    Pediatr Neurol; 2006 Aug; 35(2):158-61. PubMed ID: 16876018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional and exercise-based therapies in the treatment of mitochondrial disease.
    Mahoney DJ; Parise G; Tarnopolsky MA
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):619-29. PubMed ID: 12394637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status].
    Menke T
    Georgian Med News; 2008 Mar; (156):24-32. PubMed ID: 18403806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapies for mitochondrial diseases and current clinical trials.
    El-Hattab AW; Zarante AM; Almannai M; Scaglia F
    Mol Genet Metab; 2017 Nov; 122(3):1-9. PubMed ID: 28943110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of clinical trials for mitochondrial disorders: 1997-2012.
    Kerr DS
    Neurotherapeutics; 2013 Apr; 10(2):307-19. PubMed ID: 23361264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional support in mitochondrial diseases: the state of the art.
    Rinninella E; Pizzoferrato M; Cintoni M; Servidei S; Mele MC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4288-4298. PubMed ID: 30024619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress.
    Murray J; Oquendo CE; Willis JH; Marusich MF; Capaldi RA
    Adv Drug Deliv Rev; 2008; 60(13-14):1497-503. PubMed ID: 18647628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance.
    Suchy J; Chan A; Shea TB
    Nutr Res; 2009 Jan; 29(1):70-4. PubMed ID: 19185780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.
    Pagano G; Aiello Talamanca A; Castello G; Cordero MD; d'Ischia M; Gadaleta MN; Pallardó FV; Petrović S; Tiano L; Zatterale A
    Int J Mol Sci; 2014 Nov; 15(11):20169-208. PubMed ID: 25380523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatine monohydrate as a therapeutic aid in muscular dystrophy.
    Pearlman JP; Fielding RA
    Nutr Rev; 2006 Feb; 64(2 Pt 1):80-8. PubMed ID: 16536185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes.
    Aly HA; Domènech O
    Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption.
    Monroe RK; Halvorsen SW
    Neurotoxicology; 2009 Jul; 30(4):589-98. PubMed ID: 19635391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options.
    Tarnopolsky MA; Raha S
    Med Sci Sports Exerc; 2005 Dec; 37(12):2086-93. PubMed ID: 16331134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies.
    Tarnopolsky MA; Roy BD; MacDonald JR
    Muscle Nerve; 1997 Dec; 20(12):1502-9. PubMed ID: 9390662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.